Performance of the SeptiCyte LAB Test for Antibiotic Stewardship in Mesenteric Ischemia

NCT06507423 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 15

Last updated 2025-04-02

No results posted yet for this study

Summary

This study will help determine whether the SeptiCyte LAB test can accurately differentiate between SIRS and actual infections in postoperative patients, potentially reducing unnecessary antibiotic use and improving patient outcomes in cases of acute mesenteric ischemia

Conditions

  • Acute Mesenteric Ischemia
  • Sepsis Bacterial
  • Intra-abdominal Infection
  • Digestive Inflammation

Interventions

DEVICE

Septicyte Lab Test pre operative

SeptiCyte® technology uses proprietary biomarker signatures to assess the response of a patient's immune system to infections. It provides a score which can be used to differentiate sepsis from systemic inflammatory response. Each included patient will received the Septicyte LAB test before and after surgery for acute mesenteric ischemia suspicion. The results will be compared to standard of care, retrospectively.

DEVICE

Septicyte Lab Test post operative

SeptiCyte® technology uses proprietary biomarker signatures to assess the response of a patient's immune system to infections. It provides a score which can be used to differentiate sepsis from systemic inflammatory response. Each included patient will received the Septicyte LAB test before and after surgery for acute mesenteric ischemia suspicion. The results will be compared to standard of care, retrospectively.

Sponsors & Collaborators

  • Central Hospital, Nancy, France

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-08-01
Primary Completion
2024-09-01
Completion
2024-11-01
FDA Device
Yes

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06507423 on ClinicalTrials.gov